Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences

por Balermpas, P, Rödel, F, Liberz, R, Oppermann, J, Wagenblast, J, Ghanaati, S, Harter, P N, Mittelbronn, M, Weiss, C, Rödel, C, Fokas, E
Publicado 2014

Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach

por Murphy, Á C, Weyhenmeyer, B, Schmid, J, Kilbride, S M, Rehm, M, Huber, H J, Senft, C, Weissenberger, J, Seifert, V, Dunst, M, Mittelbronn, M, Kögel, D, Prehn, J H M, Murphy, B M
Publicado 2013

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

por Zeiner, P. S., Zinke, J., Kowalewski, D. J., Bernatz, S., Tichy, J., Ronellenfitsch, M. W., Thorsen, F., Berger, A., Forster, M. T., Muller, A., Steinbach, J. P., Beschorner, R., Wischhusen, J., Kvasnicka, H. M., Plate, K. H., Stefanović, S., Weide, B., Mittelbronn, M., Harter, P. N.
Publicado 2018